Cargando…
Functional connectivity among brain regions affected in Alzheimer’s disease is associated with CSF TNF-α in APOE4 carriers
It is now recognized that understanding how neuroinflammation affects brain function may provide new insights into Alzheimer’s pathophysiology. Tumor necrosis factor (TNF)-α, an inflammatory cytokine marker, has been implicated in Alzheimer’s disease (AD), as it can impair neuronal function through...
Autores principales: | Contreras, Joey Annette, Aslanyan, Vahan, Sweeney, Melanie D., Sanders, Lianne M.J., Sagare, Abhay P., Zlokovic, Berislav V., Toga, Arthur W., Han, S. Duke, Morris, John C., Fagan, Anne, Massoumzadeh, Parinaz, Benzinger, Tammie L., Pa, Judy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205323/ https://www.ncbi.nlm.nih.gov/pubmed/31870643 http://dx.doi.org/10.1016/j.neurobiolaging.2019.10.013 |
Ejemplares similares
-
Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease
por: Sweeney, Melanie D, et al.
Publicado: (2015) -
Higher baseline levels of CSF inflammation increase risk of incident mild cognitive impairment and Alzheimer's disease dementia
por: Contreras, Joey A., et al.
Publicado: (2022) -
APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline
por: Montagne, Axel, et al.
Publicado: (2020) -
Evidence that blood–CSF barrier transport, but not inflammatory biomarkers, change in migraine, while CSF sVCAM1 associates with migraine frequency and CSF fibrinogen
por: Cowan, Robert P., et al.
Publicado: (2021) -
Decreased functional connectivity is associated with increased levels of Cerebral Spinal Fluid soluble-PDGFRβ, a marker of blood brain barrier breakdown, in older adults
por: Contreras, Joey Annette, et al.
Publicado: (2023)